NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

INSM

Insmed Inc

Jul 02 • 09:34AM ET

97.37

Dollar change -0.25
Percentage change -0.26	%

Healthcare • Biotechnology • USA • NASD

Peers: VRTX BIIB REGN GILD RARE NBIX UTHR SRPT EXEL BMRN

| Held by: VTI VB VXF VBK XBI IBB IWP IWF IWR VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-5.95	Insider Own	2.23%	Shs Outstand	189.95M	Perf Week	-7.13%
Market Cap	18.50B	Forward P/E	-	EPS next Y	-3.66	Insider Trans	-23.52%	Shs Float	185.72M	Perf Month	35.84%
Enterprise Value	18.61B	PEG	-	EPS next Q	-1.30	Inst Own	104.81%	Short Float	6.27%	Perf Quarter	35.24%
Income	-1013.26M	P/S	48.54	EPS this Y	6.01%	Inst Trans	4.21%	Short Ratio	3.09	Perf Half Y	39.88%
Sales	381.03M	P/B	178.62	EPS next Y	30.10%	ROA	-68.42%	Short Interest	11.65M	Perf YTD	41.03%
Book/sh	0.55	P/C	15.42	EPS next 5Y	47.55%	ROE	-890.75%	52W High	106.83 -8.86%	Perf Year	45.33%
Cash/sh	6.31	P/FCF	-	EPS past 3/5Y	-12.84% -13.12%	ROIC	-72.45%	52W Low	60.40 61.21%	Perf 3Y	362.57%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	24.50% 21.66%	Gross Margin	75.17%	Volatility	3.16% 3.80%	Perf 5Y	258.77%
Dividend TTM	-	EV/Sales	48.83	EPS Y/Y TTM	-13.60%	Oper. Margin	-225.44%	ATR (14)	3.45	Perf 10Y	296.46%
Dividend Ex-Date	-	Quick Ratio	5.44	Sales Y/Y TTM	20.77%	Profit Margin	-265.93%	RSI (14)	60.82	Recom	1.05
Dividend Gr. 3/5Y	- -	Current Ratio	5.86	EPS Q/Q	-34.07%	SMA20	2.91%	Beta	0.95	Target Price	112.00
Payout	-	Debt/Eq	13.21	Sales Q/Q	22.94%	SMA50	22.97%	Rel Volume	0.18	Prev Close	97.62
Employees	1271	LT Debt/Eq	13.10	Earnings	May 08 BMO	SMA200	29.71%	Avg Volume	3.77M	Price	97.37
IPO	Feb 15, 1991	Option/Short	Yes / Yes	EPS/Sales Surpr.	-6.07% 1.48%	Trades		Volume	40,881	Change	-0.26%

Date	Action	Analyst	Rating Change	Price Target Change
May-13-25	Initiated	Jefferies	Buy	$105
Feb-25-25	Initiated	RBC Capital Mkts	Outperform	$100
Apr-23-24	Initiated	Truist	Buy	$48
Feb-15-24	Initiated	Wolfe Research	Outperform	$42
Dec-08-23	Initiated	Wells Fargo	Overweight	$55
Nov-20-23	Resumed	JP Morgan	Overweight	$36
Jul-26-23	Initiated	Guggenheim	Buy	$50
Dec-09-22	Initiated	Mizuho	Buy	$28
Dec-07-22	Initiated	Barclays	Overweight	$37
Nov-18-22	Initiated	BofA Securities	Buy	$39
Apr-27-22	Initiated	Goldman	Buy	$56
Dec-06-21	Initiated	JP Morgan	Overweight	$45
Oct-19-21	Resumed	Morgan Stanley	Overweight	$56 → $52
Oct-19-21	Resumed	Monness Crespi & Hardt	Buy	$52
Oct-08-21	Initiated	Cantor Fitzgerald	Overweight	$60
Apr-26-21	Resumed	Credit Suisse	Outperform	$60
Dec-17-20	Initiated	Berenberg	Buy	$48
Oct-12-20	Resumed	Stifel	Buy	$44
Sep-03-19	Initiated	Goldman	Buy	$30
Apr-09-19	Reiterated	H.C. Wainwright	Buy	$43 → $52

Show Previous Ratings

Jun-20-25 07:08AM	Russell Rebalance: 3 Stocks Ready to Move Higher (MarketBeat)
Jun-17-25 11:23AM	Wells Fargo Lifts Price Target on Insmed Incorporated (INSM) to $119 From $107 (Insider Monkey)
Jun-13-25 02:10PM	Insmed Incorporated (INSM) Soars on Positive PAH Therapy Trial Results (Insider Monkey)
06:00AM	AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans (BioPharma Dive)
Jun-12-25 06:37PM	Insmed (INSM) Soars After Raising $650 million (Insider Monkey)
06:32PM	Loading…
06:32PM	Insmed Inc (INSM) Soars 30% on Impressive Study (Insider Monkey)
Jun-11-25 10:25PM	Insmed Announces Pricing of $750 Million Public Offering of Common Stock (PR Newswire) +7.75%
07:40PM	Analyst Kelly Shi from Jefferies Maintained a Buy Rating on Insmed Incorporated (INSM) (Insider Monkey)
04:01PM	Insmed Announces Proposed $650 Million Public Offering of Common Stock (PR Newswire)
01:32PM	Insmed's Pulmonary Hypertension Drug Data Exceeded Even Bullish Outlook, Analysts Boost Price Forecast (Benzinga)
11:04AM	Insmed Stock Jumps 29% on Encouraging PAH Study Results (Zacks)
06:20AM	Should iShares Russell 2000 Growth ETF (IWO) Be on Your Investing Radar? (Zacks)
05:57AM	Insmed surges on lung drug data; Recursion cuts staff (BioPharma Dive)
Jun-10-25 06:08PM	Insmed CEO Will Lewis on stock surge after positive trial results (CNBC TV) +28.65%
04:07PM	Insmed Catapults Into Breakout Territory On A 'Home Run' For Its Rival To United, Liquidia (Investor's Business Daily)
02:48PM	Loading…
02:48PM	Insmed Stock Soars on Pulmonary Arterial Hypertension Drug Trial Results (Investopedia)
01:07PM	OpenAI-Google cloud deal, metals rally, Insmed trial results (Yahoo Finance Video)
11:32AM	TSMC revenue jump, Insmed stock skyrockets: Trending Tickers (Yahoo Finance Video)
11:29AM	Insmed Stock Jumps 28% on Experimental Hypertension Drug Trial Results (Barrons.com)
09:52AM	Insmed Stock Skyrockets Following Experimental Drug Trial Results (Barrons.com)
07:00AM	Insmed Announces Positive Topline Results from Phase 2b Study of Treprostinil Palmitil Inhalation Powder (TPIP) as Once-Daily Therapy in Patients with Pulmonary Arterial Hypertension (PR Newswire)
Jun-06-25 06:20AM	Should Vanguard Russell 2000 Growth ETF (VTWG) Be on Your Investing Radar? (Zacks)
06:20AM	Should Vanguard Russell 2000 ETF (VTWO) Be on Your Investing Radar? (Zacks)
Jun-04-25 04:05PM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
May-29-25 06:20AM	Should Global X Russell 2000 ETF (RSSL) Be on Your Investing Radar? (Zacks)
May-28-25 07:10AM	Insmed To Present at the 2025 Goldman Sachs Annual Global Healthcare Conference (PR Newswire)
May-21-25 04:05PM	Brensocatib Shows Consistent Efficacy and Safety Across Three Prespecified Subgroups in New Data from Landmark ASPEN Study (PR Newswire)
May-15-25 06:20AM	Should iShares Russell 2000 ETF (IWM) Be on Your Investing Radar? (Zacks)
May-14-25 07:39AM	Insmed Incorporated (INSM): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying (Insider Monkey)
May-13-25 09:16AM	Unlocking Insmed (INSM) International Revenues: Trends, Surprises, and Prospects (Zacks)
12:41PM	Loading…
May-09-25 12:41PM	Insmed's Q1 Loss Wider Than Expected, Sales Match Estimates (Zacks)
10:21AM	Is Insmed Incorporated (INSM) One of the Best Cancer Stocks to Invest in for Long-Term Gain? (Insider Monkey)
May-08-25 08:15AM	Insmed (INSM) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:13AM	Insmed: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	Insmed Reports First-Quarter 2025 Financial Results and Provides Business Update (PR Newswire)
May-07-25 06:00PM	Here are the major earnings before the open tomorrow (Seeking Alpha)
12:11PM	Insmed Q1 2025 Earnings Preview (Seeking Alpha)
May-06-25 06:20AM	Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? (Zacks) -6.49%
May-04-25 11:38AM	Insmed Incorporated (INSM): Among the Large-Cap Stocks Insiders and Short Sellers Are Dumping Like Crazy (Insider Monkey)
May-01-25 11:35AM	ClearBridge Small Cap Growth Fund Q1 2025 Commentary (Seeking Alpha)
10:01AM	Earnings Preview: Insmed (INSM) Q1 Earnings Expected to Decline (Zacks)
Apr-30-25 02:34PM	Insmed Incorporated (INSM): Among Billionaire George Soros' Mid-Cap Stocks With Huge Upside Potential (Insider Monkey)
Apr-29-25 09:30PM	Franklin Convertible Securities Fund Q1 2025 Commentary (Seeking Alpha)
11:30AM	Baron Health Care Fund Q1 2025 Top Contributors And Detractors (Seeking Alpha)
07:00AM	Insmed To Present at the BofA Securities 2025 Health Care Conference (PR Newswire)
Apr-27-25 02:22PM	Baron Health Care Fund Q1 2025 Shareholder Letter (Seeking Alpha)
Apr-25-25 11:58AM	Insmed: Poised For Transformation Beyond ARIKAYCE (Seeking Alpha)
Apr-24-25 02:50PM	TimesSquare U.S. Mid Cap Growth Strategy Q1 2025 Commentary (Seeking Alpha)
07:00AM	Insmed Announces Redemption of all $569.5 Million of Remaining Outstanding 0.75% Convertible Senior Notes Due 2028 (PR Newswire)
Apr-23-25 08:46PM	Insmed Incorporated (INSM): Among Takeover Rumors Hedge Funds Are Buying (Insider Monkey)
05:00PM	New England Journal of Medicine Publishes Positive Results from Insmed's Pivotal Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis (PR Newswire)
02:58PM	TimesSquare U.S. Small Cap Growth Strategy Q1 2025 Commentary (Seeking Alpha)
07:00AM	Insmed to Host First-Quarter 2025 Financial Results Conference Call on Thursday, May 8, 2025 (PR Newswire)
Apr-22-25 03:27AM	Polaris Global Equity Composite Q1 2025 Commentary (Seeking Alpha)
Apr-21-25 06:20AM	Should iShares Morningstar Small-Cap ETF (ISCB) Be on Your Investing Radar? (Zacks)
Apr-11-25 06:20AM	Should iShares Russell 2000 Growth ETF (IWO) Be on Your Investing Radar? (Zacks) +5.80%
Apr-08-25 02:09PM	Is Insmed Incorporated (INSM) the Best Long Term Growth Stock to Buy According to Billionaires? (Insider Monkey)
Apr-07-25 06:20AM	Should iShares Morningstar Small-Cap Growth ETF (ISCG) Be on Your Investing Radar? (Zacks)
Apr-04-25 06:20AM	Should Vanguard Russell 2000 Growth ETF (VTWG) Be on Your Investing Radar? (Zacks) -5.66%
Apr-02-25 09:50AM	Insmed Incorporated (INSM): Insiders Were Dumping in Q1 2025 (Insider Monkey)
Mar-31-25 06:20AM	Should Vanguard Russell 2000 ETF (VTWO) Be on Your Investing Radar? (Zacks)
Mar-28-25 06:20AM	Should Global X Russell 2000 ETF (RSSL) Be on Your Investing Radar? (Zacks)
Mar-25-25 05:39PM	Is Insmed Incorporated (INSM) a Promising Biotech Stock According to Wall Street Analysts (InsiderMonkey)
08:00AM	Insmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International Conference (PR Newswire)
Mar-21-25 07:10AM	BlackRock Advantage Small Cap Growth Fund Q4 2024 Commentary (SeekingAlpha)
Mar-18-25 05:33AM	Insmed Incorporated (INSM): Among the Best Biotech Stocks to Buy According to Billionaires (Insider Monkey)
Mar-10-25 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Feb-24-25 09:15AM	International Markets and Insmed (INSM): A Deep Dive for Investors (Zacks)
08:00AM	Insmed Announces that FDA Does Not Currently Plan to Hold Advisory Committee Meeting to Discuss New Drug Application for Brensocatib in Patients with Bronchiectasis (PR Newswire)
Feb-21-25 02:04AM	Insmed Inc (INSM) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
Feb-20-25 09:30AM	Insmed (INSM) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
08:15AM	Insmed (INSM) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:20AM	Insmed: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Insmed Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides Business Update (PR Newswire)
Feb-19-25 09:50AM	Will Insmed Incorporateds (INSM) New Drugs be Able to Peak Sales? (Insider Monkey)
Feb-17-25 09:16AM	Countdown to Insmed (INSM) Q4 Earnings: Wall Street Forecasts for Key Metrics (Zacks)
Feb-13-25 10:01AM	Insmed (INSM) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release (Zacks)
Feb-11-25 08:00AM	Insmed To Present at March 2025 Investor Conferences (PR Newswire)
Feb-10-25 08:00AM	Insmed to Host Fourth-Quarter and Full-Year 2024 Financial Results Conference Call on Thursday, February 20, 2025 (PR Newswire)
Feb-07-25 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Feb-06-25 08:00AM	FDA Grants Priority Review to Insmed's Brensocatib for Treatment of Bronchiectasis with PDUFA Target Action Date Set for August 12, 2025 (PR Newswire)
Jan-24-25 03:00AM	Gene therapies have been uneven for DMD but these companies hope to turn the tide (Pharma Voice)
Jan-18-25 05:46PM	Is Insmed Incorporated (INSM) One of the Best Russell 2000 Stocks to Invest in According to Analysts? (Insider Monkey)
Jan-15-25 12:29PM	Insmeds gene therapy poised to challenge DMD landscape after IND clearance (Pharmaceutical Technology)
Jan-13-25 03:06PM	Why INSM Stock Is Advancing Today (Insider Monkey) +5.64%
Jan-10-25 08:00AM	Insmed Provides Business Update at 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Jan-03-25 04:05PM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Jan-02-25 08:00AM	Insmed To Present at the 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Jan-01-25 09:40AM	Why Is Insmed Incorporated (INSM) Among the Best Multibagger Stocks to Buy Right Now? (Insider Monkey)
Dec-23-24 10:33AM	Is Insmed Incorporated (INSM) the Best Performing Biotech Stock in 2024? (Insider Monkey)
Dec-09-24 07:51AM	Should You Invest in Insmed Incorporated (INSM)? (Insider Monkey)
Dec-06-24 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Dec-02-24 02:35PM	Why Is Insmed Incorporated (INSM) Among the Best High Growth Healthcare Stocks to Invest In Now? (Insider Monkey)
08:00AM	Insmed To Present at December 2024 Investor Conferences (PR Newswire)
Nov-07-24 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Nov-06-24 08:00AM	Insmed To Present at November 2024 Investor Conferences (PR Newswire) +5.14%
Nov-04-24 09:15AM	Insmed (INSM) Reliance on International Sales: What Investors Need to Know (Zacks)
Nov-01-24 09:22AM	Do You Believe in the Growth Potential of Insmed (INSM)? (Insider Monkey)
03:03AM	Insmed Inc (INSM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
01:58AM	Q3 2024 Insmed Inc Earnings Call (Thomson Reuters StreetEvents)

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lewis William	Officer	Jul 01 '25	Proposed Sale	98.30	6,830	671,409		Jul 01 04:47 PM
Bonstein Sara	Chief Financial Officer	Jun 23 '25	Option Exercise	19.16	47,889	917,479	151,301	Jun 25 04:18 PM
Bonstein Sara	Chief Financial Officer	Jun 23 '25	Sale	101.78	57,765	5,879,089	93,536	Jun 25 04:18 PM
Bonstein Sara	Officer	Jun 23 '25	Proposed Sale	101.75	57,765	5,877,434		Jun 23 04:11 PM
Wise John Drayton	Former Officer	Jun 23 '25	Proposed Sale	104.97	20,000	2,099,400		Jun 23 04:11 PM
Lewis William	Chair and CEO	Jun 16 '25	Option Exercise	10.85	129,805	1,408,384	363,729	Jun 18 04:16 PM
Lewis William	Chair and CEO	Jun 16 '25	Sale	100.39	129,805	13,031,681	233,924	Jun 18 04:16 PM
Lewis William	Chair and CEO	Jun 16 '25	Sale	100.32	5,204	522,063	303,554	Jun 18 04:16 PM
Adsett Roger	Chief Operating Officer	Jun 16 '25	Sale	98.82	10,686	1,056,004	130,637	Jun 18 04:15 PM
Lewis William	Officer	Jun 16 '25	Proposed Sale	100.36	135,009	13,549,587		Jun 16 05:01 PM
Adsett Roger	Officer	Jun 16 '25	Proposed Sale	98.79	10,686	1,055,688		Jun 16 04:08 PM
Wise John Drayton	Former Officer	Jun 13 '25	Proposed Sale	98.01	4,486	439,681		Jun 13 04:04 PM
Flammer Martina M.D.	Chief Medical Officer	Jun 10 '25	Option Exercise	26.46	25,740	681,080	108,851	Jun 12 04:21 PM
Flammer Martina M.D.	Chief Medical Officer	Jun 11 '25	Option Exercise	17.07	19,423	331,551	102,534	Jun 12 04:21 PM
Flammer Martina M.D.	Chief Medical Officer	Jun 10 '25	Sale	88.64	25,740	2,281,594	83,111	Jun 12 04:21 PM
Flammer Martina M.D.	Chief Medical Officer	Jun 11 '25	Sale	94.50	19,423	1,835,474	83,111	Jun 12 04:21 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	Jun 11 '25	Option Exercise	13.91	70,000	973,700	188,579	Jun 12 04:20 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	Jun 10 '25	Option Exercise	17.16	38,300	657,228	156,879	Jun 12 04:20 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	Jun 11 '25	Sale	93.42	99,172	9,264,345	89,407	Jun 12 04:20 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	Jun 10 '25	Sale	88.64	38,300	3,394,912	118,579	Jun 12 04:20 PM
Bonstein Sara	Chief Financial Officer	Jun 10 '25	Option Exercise	18.02	47,890	862,884	161,178	Jun 12 04:19 PM
Bonstein Sara	Chief Financial Officer	Jun 10 '25	Sale	89.12	57,766	5,148,024	103,412	Jun 12 04:19 PM
Flammer Martina M.D.	Officer	Jun 11 '25	Proposed Sale	94.47	19,423	1,834,890		Jun 11 04:41 PM
Schaeffer Orlov S Nicole	Officer	Jun 11 '25	Proposed Sale	93.39	99,172	9,261,326		Jun 11 04:19 PM
Bonstein Sara	Officer	Jun 10 '25	Proposed Sale	89.09	57,766	5,146,207		Jun 10 05:24 PM
Flammer Martina M.D.	Officer	Jun 10 '25	Proposed Sale	88.61	25,740	2,280,821		Jun 10 05:18 PM
Schaeffer Orlov S Nicole	Officer	Jun 10 '25	Proposed Sale	88.61	38,300	3,393,763		Jun 10 05:13 PM
ALFRED ALTOMARI	Director	Jun 10 '25	Proposed Sale	70.68	25,000	1,767,000		Jun 10 04:24 PM
Smith Michael Alexander	Chief Legal Officer	Jun 05 '25	Sale	73.50	1,879	138,106	67,718	Jun 06 04:53 PM
Smith Michael Alexander	Officer	Jun 05 '25	Proposed Sale	73.47	1,879	138,050		Jun 05 04:38 PM
Smith Michael Alexander	Chief Legal Officer	Jun 03 '25	Sale	71.50	1,448	103,532	69,597	Jun 04 05:38 PM
Flammer Martina M.D.	Chief Medical Officer	Jun 03 '25	Sale	71.50	1,686	120,549	83,111	Jun 04 05:37 PM
Adsett Roger	Chief Operating Officer	Jun 03 '25	Sale	71.50	1,860	132,990	141,323	Jun 04 05:36 PM
Bonstein Sara	Chief Financial Officer	Jun 03 '25	Sale	71.50	1,579	112,898	113,288	Jun 04 05:36 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	Jun 03 '25	Sale	71.50	1,642	117,403	118,579	Jun 04 04:42 PM
MCGIRR DAVID W J	Director	Jun 03 '25	Sale	71.30	3,250	231,725	100,723	Jun 04 04:41 PM
MCGIRR DAVID W J	Director	Jun 04 '25	Sale	73.27	3,000	219,810	97,723	Jun 04 04:41 PM
Lewis William	Chair and CEO	Jun 02 '25	Option Exercise	10.85	6,830	74,106	240,754	Jun 04 04:40 PM
Lewis William	Chair and CEO	Jun 02 '25	Sale	71.31	6,830	487,044	233,924	Jun 04 04:40 PM
Lewis William	Chair and CEO	Jun 03 '25	Sale	71.50	5,472	391,248	308,758	Jun 04 04:40 PM
MCGIRR DAVID W J	Director	Jun 04 '25	Proposed Sale	73.27	3,000	219,804		Jun 04 12:33 PM
Bonstein Sara	Officer	Jun 03 '25	Proposed Sale	71.50	1,579	112,898		Jun 03 05:32 PM
Flammer Martina M.D.	Officer	Jun 03 '25	Proposed Sale	71.50	1,686	120,549		Jun 03 05:24 PM
Adsett Roger	Officer	Jun 03 '25	Proposed Sale	71.50	1,860	132,990		Jun 03 05:15 PM
Smith Michael Alexander	Officer	Jun 03 '25	Proposed Sale	71.50	1,448	103,532		Jun 03 05:09 PM
Wise John Drayton	Former Officer	Jun 03 '25	Proposed Sale	71.50	1,860	132,990		Jun 03 05:00 PM
Schaeffer Orlov S Nicole	Officer	Jun 03 '25	Proposed Sale	71.50	1,642	117,403		Jun 03 04:43 PM
Lewis William	Officer	Jun 03 '25	Proposed Sale	71.50	5,472	391,248		Jun 03 04:37 PM
Smith Michael Alexander	Chief Legal Officer	May 30 '25	Sale	69.65	26,327	1,833,779	71,045	Jun 03 04:02 PM
MCGIRR DAVID W J	Director	Jun 03 '25	Proposed Sale	71.30	3,250	231,725		Jun 03 12:50 PM
Lewis William	Officer	Jun 02 '25	Proposed Sale	71.28	6,830	486,834		Jun 02 04:35 PM
Smith Michael Alexander	Officer	May 30 '25	Proposed Sale	69.63	26,327	1,833,031		May 30 04:08 PM
Wise John Drayton	Former Officer	May 29 '25	Proposed Sale	66.60	6,691	445,620		May 29 04:22 PM
Wise John Drayton	Former Officer	May 28 '25	Proposed Sale	68.00	3,431	233,308		May 28 04:14 PM
Desjardins Clarissa	Director	May 20 '25	Buy	66.87	1,895	126,719	1,895	May 22 05:20 PM
Desjardins Clarissa	Director	May 21 '25	Buy	66.35	1,130	74,976	3,025	May 22 05:20 PM
Lewis William	Chair and CEO	May 20 '25	Option Exercise	10.85	6,830	74,106	240,754	May 22 05:18 PM
Lewis William	Chair and CEO	May 20 '25	Sale	67.65	21,057	1,424,447	314,230	May 22 05:18 PM
Lewis William	Chair and CEO	May 20 '25	Sale	67.72	6,830	462,510	233,924	May 22 05:18 PM
Wise John Drayton	Former Officer	May 20 '25	Proposed Sale	67.38	7,000	471,652		May 20 05:03 PM
Lewis William	Officer	May 20 '25	Proposed Sale	67.63	27,887	1,886,133		May 20 04:54 PM
Flammer Martina M.D.	Chief Medical Officer	May 15 '25	Sale	65.47	9,925	649,790	86,596	May 19 05:05 PM
Flammer Martina M.D.	Chief Medical Officer	May 16 '25	Sale	67.53	1,799	121,486	84,797	May 19 05:05 PM
Flammer Martina M.D.	Officer	May 15 '25	Proposed Sale	65.47	11,724	767,570		May 15 05:01 PM
Smith Michael Alexander	Chief Legal Officer	May 13 '25	Sale	67.81	4,407	298,839	92,203	May 15 04:36 PM
Smith Michael Alexander	Chief Legal Officer	May 14 '25	Sale	65.61	409	26,834	91,794	May 15 04:36 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	May 13 '25	Sale	67.81	4,999	338,982	115,879	May 15 04:34 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	May 14 '25	Sale	65.61	1,236	81,094	114,643	May 15 04:34 PM
Lewis William	Chair and CEO	May 13 '25	Sale	66.97	17,442	1,168,158	316,744	May 15 04:33 PM
Lewis William	Chair and CEO	May 14 '25	Sale	65.61	3,771	247,415	312,973	May 15 04:33 PM
Flammer Martina M.D.	Chief Medical Officer	May 13 '25	Sale	67.81	8,408	570,146	91,757	May 15 04:31 PM
Flammer Martina M.D.	Chief Medical Officer	May 14 '25	Sale	65.61	1,744	114,424	90,013	May 15 04:31 PM
Bonstein Sara	Chief Financial Officer	May 13 '25	Sale	67.81	8,870	601,475	109,993	May 15 04:29 PM
Bonstein Sara	Chief Financial Officer	May 14 '25	Sale	65.61	1,634	107,207	108,359	May 15 04:29 PM
Adsett Roger	Chief Operating Officer	May 13 '25	Sale	67.81	7,482	507,354	138,600	May 15 04:26 PM
Adsett Roger	Chief Operating Officer	May 14 '25	Sale	65.61	1,925	126,299	136,675	May 15 04:26 PM
Wise John Drayton	Former Officer	May 14 '25	Proposed Sale	65.61	401	26,309		May 14 06:23 PM
Smith Michael Alexander	Officer	May 14 '25	Proposed Sale	65.61	409	26,834		May 14 05:53 PM
Schaeffer Orlov S Nicole	Officer	May 14 '25	Proposed Sale	65.61	1,236	81,093		May 14 05:49 PM
Lewis William	Officer	May 14 '25	Proposed Sale	65.61	3,771	247,415		May 14 05:45 PM
Flammer Martina M.D.	Officer	May 14 '25	Proposed Sale	65.61	1,744	114,423		May 14 05:39 PM
Bonstein Sara	Officer	May 14 '25	Proposed Sale	65.61	1,634	107,206		May 14 05:35 PM
Adsett Roger	Officer	May 14 '25	Proposed Sale	65.61	1,925	126,299		May 14 05:30 PM
Lewis William	Officer	May 13 '25	Proposed Sale	67.81	17,442	1,182,742		May 13 05:44 PM
Bonstein Sara	Officer	May 13 '25	Proposed Sale	67.81	8,870	601,474		May 13 05:35 PM
Flammer Martina M.D.	Officer	May 13 '25	Proposed Sale	67.81	8,408	570,146		May 13 05:32 PM
Adsett Roger	Officer	May 13 '25	Proposed Sale	67.81	7,482	507,354		May 13 05:29 PM
Schaeffer Orlov S Nicole	Officer	May 13 '25	Proposed Sale	67.81	4,999	338,982		May 13 05:18 PM
Wise John Drayton	Former Officer	May 13 '25	Proposed Sale	67.81	4,610	312,604		May 13 05:12 PM
Smith Michael Alexander	Officer	May 13 '25	Proposed Sale	67.81	4,407	298,838		May 13 05:03 PM
Lewis William	Chair and CEO	May 01 '25	Option Exercise	10.85	6,830	74,106	240,754	May 02 04:43 PM
Lewis William	Chair and CEO	May 01 '25	Sale	72.57	6,830	495,668	233,924	May 02 04:43 PM
Lewis William	Officer	May 01 '25	Proposed Sale	72.54	6,830	495,448		May 01 04:33 PM
Lewis William	Chair and CEO	Apr 15 '25	Option Exercise	10.85	6,830	74,106	240,754	Apr 16 04:17 PM
Lewis William	Chair and CEO	Apr 15 '25	Sale	70.16	6,830	479,177	233,924	Apr 16 04:17 PM
Lewis William	Officer	Apr 15 '25	Proposed Sale	70.12	6,830	478,933		Apr 15 04:41 PM
Lewis William	Chair and CEO	Apr 01 '25	Option Exercise	10.85	6,830	74,106	240,754	Apr 03 04:25 PM
Lewis William	Chair and CEO	Apr 01 '25	Sale	73.58	6,830	502,577	233,924	Apr 03 04:25 PM
Lewis William	Officer	Apr 01 '25	Proposed Sale	73.55	6,830	502,352		Apr 01 04:48 PM
Lewis William	Chair and CEO	Mar 17 '25	Option Exercise	22.76	18,750	426,750	352,936	Mar 19 04:53 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

INSM

Insmed Inc

Upgrade your FINVIZ experience